SN MEDLOCK LTD

Company Registration Number:
08870413 (England and Wales)

Unaudited statutory accounts for the year ended 31 January 2024

Period of accounts

Start date: 01 February 2023

End date: 31 January 2024

SN MEDLOCK LTD

Contents of the Financial Statements

for the Period Ended 31 January 2024

Company Information - 3
Balance sheet - 4
Additional notes - 6
Balance sheet notes - 9

SN MEDLOCK LTD

Company Information

for the Period Ended 31 January 2024




Director: Naveed HUSSAIN
Registered office: 2
Medlock Way
Lees
Oldham
OL4 3LD
Company Registration Number: 08870413 (England and Wales)

SN MEDLOCK LTD

Balance sheet

As at 31 January 2024


Notes

2024
£

2023
£
Fixed assets
Intangible assets: 4 29,000 29,000
Total fixed assets: 29,000 29,000
Current assets
Stocks: 32,252 48,521
Debtors: 5 1,661
Cash at bank and in hand: 854 4,265
Total current assets: 34,767 52,786
Creditors: amounts falling due within one year: 6 ( 66,514 ) ( 102,934 )
Net current assets (liabilities): ( 31,747 ) ( 50,148 )
Total assets less current liabilities: ( 2,747 ) ( 21,148 )
Total net assets (liabilities): ( 2,747 ) ( 21,148 )

The notes form part of these financial statements

SN MEDLOCK LTD

Balance sheet continued

As at 31 January 2024


Notes

2024
£

2023
£
Capital and reserves
Called up share capital: 100 100
Profit and loss account: ( 2,847 ) ( 21,248 )
Shareholders funds: ( 2,747 ) ( 21,148 )

For the year ending 31 January 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 19 September 2024
And Signed On Behalf Of The Board By:

Name: Naveed HUSSAIN
Status: Director

The notes form part of these financial statements

SN MEDLOCK LTD

Notes to the Financial Statements

for the Period Ended 31 January 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

SN MEDLOCK LTD

Notes to the Financial Statements

for the Period Ended 31 January 2024

  • 2. Employees


    2024

    2023
    Average number of employees during the period 2 3

SN MEDLOCK LTD

Notes to the Financial Statements

for the Period Ended 31 January 2024

  • 3. Off balance sheet disclosure

    No

SN MEDLOCK LTD

Notes to the Financial Statements

for the Period Ended 31 January 2024

4. Intangible assets

Goodwill Total
Cost £ £
At 01 February 2023 29,000 29,000
Additions - -
Disposals - -
Revaluations - -
Transfers - -
At 31 January 2024 29,000 29,000
Amortisation
Amortisation at 01 February 2023 0 0
Charge for year - -
On disposals - -
Other adjustments - -
Amortisation at 31 January 2024 0 0
Net book value
Net book value at 31 January 2024 29,000 29,000
Net book value at 31 January 2023 29,000 29,000

SN MEDLOCK LTD

Notes to the Financial Statements

for the Period Ended 31 January 2024

5. Debtors


2024
£

2023
£
Prepayments and accrued income 1,661
Total 1,661

SN MEDLOCK LTD

Notes to the Financial Statements

for the Period Ended 31 January 2024

6.Creditors: amounts falling due within one year note


2024
£

2023
£
Trade creditors 9,989 49,264
Taxation and social security 2,572 2,027
Accruals and deferred income 690
Other creditors 53,953 50,953
Total 66,514 102,934

Other creditors represent Director Naveed HUSSAIN's loan a.c of £53,953 (2023: £50,953).